Janney Montgomery Scott LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1329948 PHILADELPHIA, PA

Position in ALNY

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$3,089,994

+$504,077 QoQ

Shares Held

9,339

+43.6% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Janney Montgomery Scott LLC holds $101,269,363 across 48 Biotechnology names. ALNY ranks #5 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	84,324	$37,654,038
2	SPRY	ARS Pharmaceuticals, Inc.	2,016,464	$16,192,205
3	REGN	Regeneron Pharmaceuticals, Inc.	13,078	$10,104,585
4	INCY	Incyte Corp	55,431	$5,217,165
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	9,339	$3,089,994
6	ZVRA	Zevra Therapeutics, Inc.	236,834	$2,207,292
7	INVA	Innoviva, Inc.	90,000	$2,097,000
8	AXSM	Axsome Therapeutics, Inc.	12,030	$2,033,310

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,089,994	9,339	+43.6%	Shares	Sole	2026-04-22
2025-12-31	$2,585,917	6,503	+60.4%	Shares	Sole	2026-02-11
2025-09-30	$1,849,080	4,055	+27.9%	Shares	Sole	2025-10-27
2024-12-31	$745,932	3,170	+0.6%	Shares	Sole	2025-01-17
2024-09-30	$866,619	3,151	-0.2%	Shares	Sole	2024-10-29
2024-06-30	$767,151	3,157	+13.8%	Shares	Sole	2024-07-25
2024-03-31	$414,723	2,775	+47.4%	Shares	Sole	2024-05-01
2023-12-31	$360,425	1,883	+79.2%	Shares	Sole	2024-02-08
2022-12-31	$249,770	1,051	-60.7%	Shares	Sole	2023-02-01
2022-06-30	$389,565	2,671	—	Shares	Sole	2022-08-03
No filing history on record for this holder in this stock.